Foung S K, Blunt J A, Wu P S, Ahearn P, Winn L C, Engleman E G, Grumet F C
Department of Pathology, Stanford University Medical Center, Calif.
Vox Sang. 1987;53(1):44-7. doi: 10.1111/j.1423-0410.1987.tb04912.x.
B lymphocytes from Rh negative donors with serum anti-D antibodies were isolated and fused with the mouse-human heteromyeloma, SBC-H20, to produce hybridomas secreting IgM or IgG1 human monoclonal antibodies to D antigen. The IgM antibody in hybridoma supernatant agglutinates all normal D positive cells at the immediate spin phase of reactivity. Using concentrated IgM hybridoma supernatant of approximately 50 micrograms/ml, Du cells were also agglutinated. The IgG1 antibody reacts by indirect hemagglutination with all D and Du cells. Against Rh mosaics, different reactivity was noted for each antibody. Furthermore, D positive cells precoated with the IgG1 antibody inhibit the IgM direct hemagglutination, suggesting that the antibodies identify closely associated epitopes. These human monoclonal antibodies will be useful diagnostic reagents and, ultimately, should be useful in the prevention of Rh hemolytic disease of the newborn.
从具有血清抗-D抗体的Rh阴性供体中分离出B淋巴细胞,并将其与鼠-人异源骨髓瘤SBC-H20融合,以产生分泌针对D抗原的IgM或IgG1人单克隆抗体的杂交瘤。杂交瘤上清液中的IgM抗体在反应的直接旋转阶段凝集所有正常的D阳性细胞。使用浓度约为50微克/毫升的浓缩IgM杂交瘤上清液,Du细胞也被凝集。IgG1抗体通过间接血凝反应与所有D和Du细胞发生反应。针对Rh嵌合体,每种抗体的反应性不同。此外,预先用IgG1抗体包被的D阳性细胞可抑制IgM直接血凝反应,这表明这些抗体识别紧密相关的表位。这些人单克隆抗体将是有用的诊断试剂,最终应有助于预防新生儿Rh溶血病。